Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 112

1.

Immune modulation of head and neck squamous cell carcinoma and the tumor microenvironment by conventional therapeutics.

Miyauchi S, Kim SS, Pang J, Gold KA, Gutkind JS, Califano J, Mell LK, Cohen EEW, Sharabi AB.

Clin Cancer Res. 2019 Feb 27. pii: clincanres.0871.2018. doi: 10.1158/1078-0432.CCR-18-0871. [Epub ahead of print]

PMID:
30814108
2.

Comparison of Comorbidity and Frailty Indices in Patients With Head and Neck Cancer Using an Online Tool.

Vitzthum LK, Feng CH, Noticewala S, Hines PJ, Nguyen C, Zakeri K, Sojourner EJ, Shen H, Mell LK.

JCO Clin Cancer Inform. 2018 Dec;2:1-9. doi: 10.1200/CCI.18.00082.

3.

Generalized Competing Event Models Can Reduce Cost and Duration of Cancer Clinical Trials.

Zakeri K, Panjwani N, Carmona R, Shen H, Vitzthum LK, Zhang QE, Murphy JD, Mell LK.

JCO Clin Cancer Inform. 2018 Dec;2:1-12. doi: 10.1200/CCI.17.00124.

4.

Detecting a Survival Benefit to Dose Escalation.

Zakeri K, Rose BS, Mell LK.

JAMA Oncol. 2019 Jan 1;5(1):109-110. doi: 10.1001/jamaoncol.2018.5055. No abstract available.

PMID:
30452492
5.

Incidence of Long-Term Esophageal Dilation With Various Treatment Approaches in the Older Head and Neck Cancer Population.

Green G, Kim E, Carmona R, Shen H, Murphy JD, Mell LK.

Front Oncol. 2018 Oct 23;8:466. doi: 10.3389/fonc.2018.00466. eCollection 2018.

6.

Radiation Therapy Combined With Checkpoint Blockade Immunotherapy for Metastatic Undifferentiated Pleomorphic Sarcoma of the Maxillary Sinus With a Complete Response.

Guram K, Nunez M, Einck J, Mell LK, Cohen E, Sanders PD, Miyauchi S, Weihe E, Kurzrock R, Boles S, Sharabi AB.

Front Oncol. 2018 Oct 17;8:435. doi: 10.3389/fonc.2018.00435. eCollection 2018.

7.

The role of p16 as a biomarker in nonoropharyngeal head and neck cancer.

Vitzthum LK, Mell LK.

Oncotarget. 2018 Sep 7;9(70):33247-33248. doi: 10.18632/oncotarget.26053. eCollection 2018 Sep 7. No abstract available.

8.

Intensity Modulated Radiation Therapy Versus Conventional Radiation for Anal Cancer in the Veterans Affairs System.

Bryant AK, Huynh-Le MP, Simpson DR, Mell LK, Gupta S, Murphy JD.

Int J Radiat Oncol Biol Phys. 2018 Sep 1;102(1):109-115. doi: 10.1016/j.ijrobp.2018.05.044. Epub 2018 May 23.

PMID:
30102186
9.

Definitive Radiation Therapy and Survival in Clinically Node-Positive Prostate Cancer.

Bryant AK, Kader AK, McKay RR, Einck JP, Mell LK, Mundt AJ, Kane CJ, Efstathiou JA, Murphy JD, Rose BS.

Int J Radiat Oncol Biol Phys. 2018 Aug 1;101(5):1188-1193. doi: 10.1016/j.ijrobp.2018.04.023. Epub 2018 Apr 17.

PMID:
29891203
10.

Prognostic Role of p16 in Nonoropharyngeal Head and Neck Cancer.

Bryant AK, Sojourner EJ, Vitzthum LK, Zakeri K, Shen H, Nguyen C, Murphy JD, Califano JA, Cohen EEW, Mell LK.

J Natl Cancer Inst. 2018 Dec 1;110(12):1393-1399. doi: 10.1093/jnci/djy072.

PMID:
29878161
11.

NCCN Guidelines Insights: Head and Neck Cancers, Version 1.2018.

Colevas AD, Yom SS, Pfister DG, Spencer S, Adelstein D, Adkins D, Brizel DM, Burtness B, Busse PM, Caudell JJ, Cmelak AJ, Eisele DW, Fenton M, Foote RL, Gilbert J, Gillison ML, Haddad RI, Hicks WL, Hitchcock YJ, Jimeno A, Leizman D, Maghami E, Mell LK, Mittal BB, Pinto HA, Ridge JA, Rocco J, Rodriguez CP, Shah JP, Weber RS, Witek M, Worden F, Zhen W, Burns JL, Darlow SD.

J Natl Compr Canc Netw. 2018 May;16(5):479-490. doi: 10.6004/jnccn.2018.0026.

PMID:
29752322
12.

Underutilization of brachytherapy and disparities in survival for patients with cervical cancer in California.

Mayadev J, Klapheke A, Yashar C, Hsu IC, Kamrava M, Mundt AJ, Mell LK, Einck J, Benedict S, Valicenti R, Cress R.

Gynecol Oncol. 2018 Jul;150(1):73-78. doi: 10.1016/j.ygyno.2018.04.563. Epub 2018 Apr 27.

13.

The impact of daily bladder filling on small bowel dose for intensity modulated radiation therapy for cervical cancer.

Chen VE, Gillespie EF, Manger RP, Skerritt LA, Tran JH, Proudfoot JA, Sherer MV, Einck JP, Mell LK, Moore KL, Yashar CM.

Med Dosim. 2018 Mar 21. pii: S0958-3947(18)30028-1. doi: 10.1016/j.meddos.2018.02.010. [Epub ahead of print]

PMID:
29573921
14.

The Impact of Surgeons on the Likelihood of Mastectomy in Breast Cancer.

Boero IJ, Paravati AJ, Hou J, Gillespie EF, Schoenbrunner A, Unkart J, Wallace AM, Einck JP, Mell LK, Murphy JD.

Ann Surg. 2018 Feb 20. doi: 10.1097/SLA.0000000000002698. [Epub ahead of print]

PMID:
29465454
15.

Effect of CD4 Count on Treatment Toxicity and Tumor Recurrence in Human Immunodeficiency Virus-Positive Patients With Anal Cancer.

Bryant AK, Mudgway R, Huynh-Le MP, Simpson DR, Mell LK, Gupta S, Sharabi AB, Murphy JD.

Int J Radiat Oncol Biol Phys. 2018 Feb 1;100(2):478-485. doi: 10.1016/j.ijrobp.2017.09.034. Epub 2017 Sep 22.

PMID:
29102276
16.

Phase I Trial of Intravenous Oncolytic Vaccinia Virus (GL-ONC1) with Cisplatin and Radiotherapy in Patients with Locoregionally Advanced Head and Neck Carcinoma.

Mell LK, Brumund KT, Daniels GA, Advani SJ, Zakeri K, Wright ME, Onyeama SJ, Weisman RA, Sanghvi PR, Martin PJ, Szalay AA.

Clin Cancer Res. 2017 Oct 1;23(19):5696-5702. doi: 10.1158/1078-0432.CCR-16-3232. Epub 2017 Jul 5.

17.

NCCN Guidelines Insights: Head and Neck Cancers, Version 2.2017.

Adelstein D, Gillison ML, Pfister DG, Spencer S, Adkins D, Brizel DM, Burtness B, Busse PM, Caudell JJ, Cmelak AJ, Colevas AD, Eisele DW, Fenton M, Foote RL, Gilbert J, Haddad RI, Hicks WL Jr, Hitchcock YJ, Jimeno A, Leizman D, Lydiatt WM, Maghami E, Mell LK, Mittal BB, Pinto HA, Ridge JA, Rocco J, Rodriguez CP, Shah JP, Weber RS, Witek M, Worden F, Yom SS, Zhen W, Burns JL, Darlow SD.

J Natl Compr Canc Netw. 2017 Jun;15(6):761-770. doi: 10.6004/jnccn.2017.0101.

PMID:
28596256
18.

Feasibility of atlas-based active bone marrow sparing intensity modulated radiation therapy for cervical cancer.

Li N, Noticewala SS, Williamson CW, Shen H, Sirak I, Tarnawski R, Mahantshetty U, Hoh CK, Moore KL, Mell LK.

Radiother Oncol. 2017 May;123(2):325-330. doi: 10.1016/j.radonc.2017.02.017.

PMID:
28528206
19.

In Reply to Singh.

INTERTECC Study Group, Mell LK, Sirák I, Mahantshetty U.

Int J Radiat Oncol Biol Phys. 2017 Jun 1;98(2):483-484. doi: 10.1016/j.ijrobp.2017.02.011. No abstract available.

PMID:
28463171
20.

Longitudinal Changes in Active Bone Marrow for Cervical Cancer Patients Treated With Concurrent Chemoradiation Therapy.

Noticewala SS, Li N, Williamson CW, Hoh CK, Shen H, McHale MT, Saenz CC, Einck J, Plaxe S, Vaida F, Yashar CM, Mell LK.

Int J Radiat Oncol Biol Phys. 2017 Mar 15;97(4):797-805. doi: 10.1016/j.ijrobp.2016.11.033. Epub 2016 Nov 29.

PMID:
28244416
21.

The Impact of Radiation Oncologists on the Early Adoption of Hypofractionated Radiation Therapy for Early-Stage Breast Cancer.

Boero IJ, Gillespie EF, Hou J, Paravati AJ, Kim E, Einck JP, Yashar C, Mell LK, Murphy JD.

Int J Radiat Oncol Biol Phys. 2017 Mar 1;97(3):571-580. doi: 10.1016/j.ijrobp.2016.11.009. Epub 2016 Nov 15.

PMID:
28126306
22.

Bone Marrow-sparing Intensity Modulated Radiation Therapy With Concurrent Cisplatin For Stage IB-IVA Cervical Cancer: An International Multicenter Phase II Clinical Trial (INTERTECC-2).

Mell LK, Sirák I, Wei L, Tarnawski R, Mahantshetty U, Yashar CM, McHale MT, Xu R, Honerkamp-Smith G, Carmona R, Wright M, Williamson CW, Kasaová L, Li N, Kry S, Michalski J, Bosch W, Straube W, Schwarz J, Lowenstein J, Jiang SB, Saenz CC, Plaxe S, Einck J, Khorprasert C, Koonings P, Harrison T, Shi M, Mundt AJ; INTERTECC Study Group.

Int J Radiat Oncol Biol Phys. 2017 Mar 1;97(3):536-545. doi: 10.1016/j.ijrobp.2016.11.027. Epub 2016 Nov 23.

PMID:
28126303
23.

Trends in Radiation Therapy among Cancer Survivors in the United States, 2000-2030.

Bryant AK, Banegas MP, Martinez ME, Mell LK, Murphy JD.

Cancer Epidemiol Biomarkers Prev. 2017 Jun;26(6):963-970. doi: 10.1158/1055-9965.EPI-16-1023. Epub 2017 Jan 17.

24.

Highly Efficient Training, Refinement, and Validation of a Knowledge-based Planning Quality-Control System for Radiation Therapy Clinical Trials.

Li N, Carmona R, Sirak I, Kasaova L, Followill D, Michalski J, Bosch W, Straube W, Mell LK, Moore KL.

Int J Radiat Oncol Biol Phys. 2017 Jan 1;97(1):164-172. doi: 10.1016/j.ijrobp.2016.10.005. Epub 2016 Oct 13.

25.

Prospective Validation of a High Dimensional Shape Model for Organ Motion in Intact Cervical Cancer.

Williamson CW, Green G, Noticewala SS, Li N, Shen H, Vaida F, Mell LK.

Int J Radiat Oncol Biol Phys. 2016 Nov 15;96(4):801-807. doi: 10.1016/j.ijrobp.2016.08.015. Epub 2016 Aug 22.

26.

Cost-Effectiveness Analysis of Elective Neck Dissection in Patients With Clinically Node-Negative Oral Cavity Cancer.

Acevedo JR, Fero KE, Wilson B, Sacco AG, Mell LK, Coffey CS, Murphy JD.

J Clin Oncol. 2016 Nov 10;34(32):3886-3891. doi: 10.1200/JCO.2016.68.4563.

27.

Specificity of Genetic Biomarker Studies in Cancer Research: A Systematic Review.

Green G, Carmona R, Zakeri K, Lee CH, Borgan S, Marhoon Z, Sharabi A, Mell LK.

PLoS One. 2016 Jul 6;11(7):e0156489. doi: 10.1371/journal.pone.0156489. eCollection 2016. Review.

28.

Modern Radiation Therapy and Cardiac Outcomes in Breast Cancer.

Boero IJ, Paravati AJ, Triplett DP, Hwang L, Matsuno RK, Gillespie EF, Yashar CM, Moiseenko V, Einck JP, Mell LK, Parikh SA, Murphy JD.

Int J Radiat Oncol Biol Phys. 2016 Mar 15;94(4):700-8. doi: 10.1016/j.ijrobp.2015.12.018. Epub 2015 Dec 17.

PMID:
26972642
29.

Improved Method to Stratify Elderly Patients With Cancer at Risk for Competing Events.

Carmona R, Zakeri K, Green G, Hwang L, Gulaya S, Xu B, Verma R, Williamson CW, Triplett DP, Rose BS, Shen H, Vaida F, Murphy JD, Mell LK.

J Clin Oncol. 2016 Apr 10;34(11):1270-7. doi: 10.1200/JCO.2015.65.0739. Epub 2016 Feb 16.

30.

Radiation sparing of cerebral cortex in brain tumor patients using quantitative neuroimaging.

Karunamuni RA, Moore KL, Seibert TM, Li N, White NS, Bartsch H, Carmona R, Marshall D, McDonald CR, Farid N, Krishnan A, Kuperman J, Mell LK, Brewer J, Dale AM, Moiseenko V, Hattangadi-Gluth JA.

Radiother Oncol. 2016 Jan;118(1):29-34. doi: 10.1016/j.radonc.2016.01.003. Epub 2016 Jan 21.

31.

Importance of Radiation Oncologist Experience Among Patients With Head-and-Neck Cancer Treated With Intensity-Modulated Radiation Therapy.

Boero IJ, Paravati AJ, Xu B, Cohen EE, Mell LK, Le QT, Murphy JD.

J Clin Oncol. 2016 Mar 1;34(7):684-90. doi: 10.1200/JCO.2015.63.9898. Epub 2016 Jan 4.

32.

[(18)F]Fluoro-2-deoxy-2-d-glucose versus 3'-deoxy-3'-[(18)F]fluorothymidine for defining hematopoietically active pelvic bone marrow in gynecologic patients.

Wyss JC, Carmona R, Karunamuni RA, Pritz J, Hoh CK, Mell LK.

Radiother Oncol. 2016 Jan;118(1):72-8. doi: 10.1016/j.radonc.2015.11.018. Epub 2015 Dec 7.

33.

The impact of radiotherapy costs on clinical outcomes in breast cancer.

Boero IJ, Paravati AJ, Triplett DP, Hwang L, Matsuno RK, Mell LK, Murphy JD.

Radiother Oncol. 2015 Nov;117(2):393-9. doi: 10.1016/j.radonc.2015.10.004. Epub 2015 Oct 20.

34.

Cultivating Future Clinician Scientists: In Regard to Vapiwala et al.

Mell LK.

Int J Radiat Oncol Biol Phys. 2015 Oct 1;93(2):468. doi: 10.1016/j.ijrobp.2015.05.047. No abstract available.

PMID:
26383687
35.

Variation in the Cost of Radiation Therapy Among Medicare Patients With Cancer.

Paravati AJ, Boero IJ, Triplett DP, Hwang L, Matsuno RK, Xu B, Mell LK, Murphy JD.

J Oncol Pract. 2015 Sep;11(5):403-9. doi: 10.1200/JOP.2015.005694. Epub 2015 Aug 11.

36.

Head and Neck Cancers, Version 1.2015.

Pfister DG, Spencer S, Brizel DM, Burtness B, Busse PM, Caudell JJ, Cmelak AJ, Colevas AD, Dunphy F, Eisele DW, Foote RL, Gilbert J, Gillison ML, Haddad RI, Haughey BH, Hicks WL Jr, Hitchcock YJ, Jimeno A, Kies MS, Lydiatt WM, Maghami E, McCaffrey T, Mell LK, Mittal BB, Pinto HA, Ridge JA, Rodriguez CP, Samant S, Shah JP, Weber RS, Wolf GT, Worden F, Yom SS, McMillian N, Hughes M.

J Natl Compr Canc Netw. 2015 Jul;13(7):847-55; quiz 856.

37.

Clinical Outcomes of Computed Tomography-Based Volumetric Brachytherapy Planning for Cervical Cancer.

Simpson DR, Scanderbeg DJ, Carmona R, McMurtrie RM, Einck J, Mell LK, McHale MT, Saenz CC, Plaxe SC, Harrison T, Mundt AJ, Yashar CM.

Int J Radiat Oncol Biol Phys. 2015 Sep 1;93(1):150-7. doi: 10.1016/j.ijrobp.2015.04.043. Epub 2015 May 4.

PMID:
26130230
38.

Underrepresentation of Local Therapy Trials in Leading Medical Journals: Cause for Outrage or Indifference?

Mell LK, Zakeri K.

Int J Radiat Oncol Biol Phys. 2015 Jul 15;92(4):732-4. doi: 10.1016/j.ijrobp.2015.04.040. No abstract available.

PMID:
26104928
39.

Dosimetric benefit of adaptive re-planning in pancreatic cancer stereotactic body radiotherapy.

Li Y, Hoisak JD, Li N, Jiang C, Tian Z, Gautier Q, Zarepisheh M, Wu Z, Liu Y, Jia X, Hattangadi-Gluth J, Mell LK, Jiang S, Murphy JD.

Med Dosim. 2015 Winter;40(4):318-24. doi: 10.1016/j.meddos.2015.04.002. Epub 2015 May 19.

PMID:
26002122
40.

Competing events and costs of clinical trials: Analysis of a randomized trial in prostate cancer.

Zakeri K, Rose BS, D'Amico AV, Jeong JH, Mell LK.

Radiother Oncol. 2015 Apr;115(1):114-9. doi: 10.1016/j.radonc.2015.03.018. Epub 2015 Apr 6.

41.

Longitudinal study of acute haematologic toxicity in cervical cancer patients treated with chemoradiotherapy.

Zhu H, Zakeri K, Vaida F, Carmona R, Dadachanji KK, Bair R, Aydogan B, Hasan Y, Yashar CM, Mell LK.

J Med Imaging Radiat Oncol. 2015 Jun;59(3):386-93; quiz 394. doi: 10.1111/1754-9485.12297. Epub 2015 Apr 1.

42.

A segmentation and point-matching enhanced efficient deformable image registration method for dose accumulation between HDR CT images.

Zhen X, Chen H, Yan H, Zhou L, Mell LK, Yashar CM, Jiang S, Jia X, Gu X, Cervino L.

Phys Med Biol. 2015 Apr 7;60(7):2981-3002. doi: 10.1088/0031-9155/60/7/2981. Epub 2015 Mar 19.

43.

Survival in unresectable sinonasal undifferentiated carcinoma treated with concurrent intra-arterial cisplatin and radiation.

Noticewala SS, Mell LK, Olson SE, Read W.

World J Clin Cases. 2015 Feb 16;3(2):191-5. doi: 10.12998/wjcc.v3.i2.191.

44.

Introducing prospective manuscript review to address publication bias.

Mell LK, Zietman AL.

Int J Radiat Oncol Biol Phys. 2014 Nov 15;90(4):729-32. doi: 10.1016/j.ijrobp.2014.07.052. Epub 2014 Oct 18. No abstract available.

PMID:
25585776
45.

Aspiration pneumonia after concurrent chemoradiotherapy for head and neck cancer.

Xu B, Boero IJ, Hwang L, Le QT, Moiseenko V, Sanghvi PR, Cohen EE, Mell LK, Murphy JD.

Cancer. 2015 Apr 15;121(8):1303-11. doi: 10.1002/cncr.29207. Epub 2014 Dec 23.

46.

Targeting the PI3K/AKT/mTOR pathway in squamous cell carcinoma of the head and neck.

Simpson DR, Mell LK, Cohen EE.

Oral Oncol. 2015 Apr;51(4):291-8. doi: 10.1016/j.oraloncology.2014.11.012. Epub 2014 Dec 17. Review.

47.

Head and neck cancers, Version 2.2014. Clinical practice guidelines in oncology.

Pfister DG, Spencer S, Brizel DM, Burtness B, Busse PM, Caudell JJ, Cmelak AJ, Colevas AD, Dunphy F, Eisele DW, Gilbert J, Gillison ML, Haddad RI, Haughey BH, Hicks WL Jr, Hitchcock YJ, Jimeno A, Kies MS, Lydiatt WM, Maghami E, Martins R, McCaffrey T, Mell LK, Mittal BB, Pinto HA, Ridge JA, Rodriguez CP, Samant S, Schuller DE, Shah JP, Weber RS, Wolf GT, Worden F, Yom SS, McMillian NR, Hughes M; National Comprehensive Cancer Network.

J Natl Compr Canc Netw. 2014 Oct;12(10):1454-87.

48.

Proton density water fraction as a biomarker of bone marrow cellularity: validation in ex vivo spine specimens.

MacEwan IJ, Glembotski NE, D'Lima D, Bae W, Masuda K, Rashidi HH, Mell LK, Bydder M.

Magn Reson Imaging. 2014 Nov;32(9):1097-101. doi: 10.1016/j.mri.2014.03.005. Epub 2014 Mar 15.

49.

Age disparity in palliative radiation therapy among patients with advanced cancer.

Wong J, Xu B, Yeung HN, Roeland EJ, Martinez ME, Le QT, Mell LK, Murphy JD.

Int J Radiat Oncol Biol Phys. 2014 Sep 1;90(1):224-30. doi: 10.1016/j.ijrobp.2014.03.050.

50.

Fat composition changes in bone marrow during chemotherapy and radiation therapy.

Carmona R, Pritz J, Bydder M, Gulaya S, Zhu H, Williamson CW, Welch CS, Vaida F, Bydder G, Mell LK.

Int J Radiat Oncol Biol Phys. 2014 Sep 1;90(1):155-63. doi: 10.1016/j.ijrobp.2014.05.041. Epub 2014 Jul 8.

Supplemental Content

Loading ...
Support Center